SAM68: Signal transduction and RNA metabolism in human cancer

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Frisone, Paola ^a   Pradella, Davide ^b   Di Matteo, Anna ^b   Belloni, Elisa ^b   Ghigna, Claudia ^b   Paronetto, Maria Paola ^a,c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA PRECURSOR; PROTEIN SAM68; UNTRANSLATED RNA; DNA BINDING PROTEIN; KHDRBS1 PROTEIN, HUMAN; RNA; RNA BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOUSE MODEL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA METABOLISM; RNA PROCESSING; SIGNAL TRANSDUCTION; GENETICS; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BIOMARKERS, TUMOR; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICING; RNA, NEOPLASM; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84939162659     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/528954     Document Type: Review

References (136)

1. S. Fumagalli, N. F. Totty, J. J. Hsuan, and S. A. Courtneidge, "A target for Src in mitosis," Nature, vol. 368, no. 6474, pp. 871-874, 1994.
2. S. J. Taylor and D. Shalloway, "An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis," Nature, vol. 368, no. 6474, pp. 867-871, 1994.
3. C. Vernet and K. Artzt, "STAR, a gene family involved in signal transduction and activation of RNA," Trends in Genetics, vol. 13, no. 12, pp. 479-484, 1997.
4. K. E. Lukong and S. Richard, "Sam68, the KH domaincontaining superSTAR," Biochimica et Biophysica Acta: Reviews on Cancer, vol. 1653, no. 2, pp. 73-86, 2003.
5. M. Cruz-Alvarez and A. Pellicer, "Cloning of a full-length complementary DNA for an Artemia salina glycine-rich protein. Structural relationship with RNA binding proteins," Journal of Biological Chemistry, vol. 262, no. 28, pp. 13377-13380, 1987.
6. A. R. Jones and T. Schedl, "Mutations in GLD-1, a female germ cell-specific tumor suppressor gene in Caenorhabditis elegans, affect a conserved domain also found in Src- associated protein Sam68," Genes and Development, vol. 9, no. 12, pp. 1491-1504, 1995.
7. T. A. Ebersole, Q. Chen, M. J. Justice, and K. Artzt, "The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins," Nature Genetics, vol. 12, no. 3, pp. 260-265, 1996.
8. P. Lock, S. Fumagalli, P. Polakis, F. McCormick, and S. A. Courtneidge, "The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein," Cell, vol. 84, no. 1, pp. 23-24, 1996.
9. S. Richard, D. Yu, K. J. Blumer et al., "Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase Cγ-1," Molecular and Cellular Biology, vol. 15, no. 1, pp. 186-197, 1995.
10. M. di Fruscio, T. Chen, and S. Richard, "Characterization of Sam68-like mammalian proteins SLM-1 and SLM-2: SLM-1 is a Src substrate during mitosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 6, pp. 2710-2715, 1999.
11. J. P. Venables, C. Vernet, S. L. Chew et al., "T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis," Human Molecular Genetics, vol. 8, no. 6, pp. 959-969, 1999.
12. C. Fyrberg, J. Becker, P. Barthmaier, J. Mahaffey, and E. Fyrberg, "A Drosophila muscle-specific gene related to the mouse quaking locus," Gene, vol. 197, no. 1-2, pp. 315-323, 1997.
13. M. Di Fruscio, T. Chen, S. Bonyadi, P. Lasko, and S. Richard, "The identification of two Drosophila K homology domain proteins: KEP1 and SAM are members of the Sam68 family of GSG domain proteins," Journal of Biological Chemistry, vol. 273, no. 46, pp. 30122-30130, 1998.
14. S. Arning, P. Gruter, G. Bilbe, and A. Kramer, "Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA," RNA, vol. 2, no. 8, pp. 794-810, 1996.
15. C. Sette, "Post-translational regulation of star proteins and effects on their biological functions," Advances in Experimental Medicine and Biology, vol. 693, pp. 54-66, 2010.
16. S. J. Taylor, M. Anafi, T. Pawson, and D. Shalloway, "Functional interaction between c-Src and its mitotic target, Sam 68," The Journal of Biological Chemistry, vol. 270, no. 17, pp. 10120-10124, 1995.
17. T. Chen, B. B. Damaj, C. Herrera, P. Lasko, and S. Richard, "Selfassociation of the single-KH-domain family members Sam68, GRP33, GLD-1, and Qk1: role of theKHdomain,"Molecular and Cellular Biology, vol. 17, no. 10, pp. 5707-5718, 1997.
18. M. P. Paronetto, J. P. Venables, D. J. Elliott, R. Geremia, P. Rossi, and C. Sette, "tr-kit promotes the formation of a multimolecular complex composed by Fyn, PLCgamma1 and Sam68," Oncogene, vol. 22, no. 54, pp. 8707-8715, 2003.
19. M. P. Paronetto, T. Achsel, A. Massiello, C. E. Chalfant, and C. Sette, "The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x," Journal of Cell Biology, vol. 176, no. 7, pp. 929-939, 2007.
20. J. Cote, F.-M. Boisvert, M.-C. Boulanger, M. T. Bedford, and S. Richard, "Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1," Molecular Biology of the Cell, vol. 14, no. 1, pp. 274-287, 2003.
21. M. T. Bedford, A. Frankel, M. B. Yaffe, S. Clarke, P. Leder, and S. Richard, "Arginine methylation inhibits the binding of prolinerich ligands to Src homology 3, but not WW, domains," The Journal of Biological Chemistry, vol. 275, no. 21, pp. 16030-16036, 2000.
22. I. Babic, A. Jakymiw, and D. J. Fujita, "The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity," Oncogene, vol. 23, no. 21, pp. 3781-3789, 2004.
23. I. Babic, E. Cherry, and D. J. Fujita, "SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis," Oncogene, vol. 25, no. 36, pp. 4955-4964, 2006.
24. R. Francis, E. Maine, and T. Schedl, "Analysis of the multiple roles of gld-1 in germline development: interactions with the sex determination cascade and the glp-1 signaling pathway," Genetics, vol. 139, no. 2, pp. 607-630, 1995.
25. K. Liu, L. Li, P. E. Nisson, C. Gruber, J. Jessee, and S. N. Cohen, "Neoplastic transformation and tumorigenesis associated with Sam68 protein deficiency in cultured murine fibroblasts," Journal of Biological Chemistry, vol. 275, no. 51, pp. 40195-40201, 2000.
26. Q.-H. Li, I. Haga, T. Shimizu, M. Itoh, T. Kurosaki, and J.-I. Fujisawa, "Retardation of the G2-M phase progression on gene disruption of RNA binding protein Sam68 in the DT-40 cell line," FEBS Letters, vol. 525, no. 1-3, pp. 145-150, 2002.
27. I. Barlat, F. Maurier, M. Duchesne, E. Guitard, B. Tocque, and F. Schweighoffer, "A role for Sam68 in cell cycle progression antagonized by a spliced variant within the KH domain," The Journal of Biological Chemistry, vol. 272, no. 6, pp. 3129-3132, 1997.
28. S. Richard, N. Torabi, G. V. Franco et al., "Ablation of the Sam68 RNA binding protein protects mice fromage-related bone loss," PLoS Genetics, vol. 1, no. 6, article e74, 2005.
29. S. Richard, G. Vogel, M.-E. Huot, T. Guo, W. J. Muller, and K. E. Lukong, "Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis," Oncogene, vol. 27, no. 4, pp. 548-556, 2008.
30. E. Bianchi, F. Barbagallo, C. Valeri et al., "Ablation of the Sam68 gene impairs female fertility and gonadotropin-dependent follicle development," Human Molecular Genetics, vol. 19, no. 24, Article ID ddq422, pp. 4886-4894, 2010.
31. M. P. Paronetto, V. Messina, M. Barchi, R. Geremia, S. Richard, and C. Sette, "Sam68 marks the transcriptionally active stages of spermatogenesis and modulates alternative splicing in male germcells,"NucleicAcids Research, vol. 39, no. 12, pp. 4961-4974, 2011.
32. M. P. Paronetto, V. Messina, E. Bianchi et al., "Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis," Journal of Cell Biology, vol. 185, no. 2, pp. 235-249, 2009.
33. M. P. Paronetto, F. Zalfa, F. Botti, R. Geremia, C. Bagni, and C. Sette, "The nuclear RNA-binding protein Sam68 translocates to the cytoplasm and associates with the polysemes in mouse spermatocytes," Molecular Biology of the Cell, vol. 17, no. 1, pp. 14-24, 2006.
34. T. Iijima, K. Wu, H. Witte et al., "SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1," Cell, vol. 147, no. 7, pp. 1601-1614, 2011.
35. M.-E. Huot, G. Vogel, A. Zabarauskas et al., "The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis," Molecular Cell, vol. 46, no. 2, pp. 187-199, 2012.
36. K. E. Lukong and S. Richard, "Targeting the RNA-binding protein Sam68 as a treatment for cancer?" Future Oncology, vol. 3, no. 5, pp. 539-544, 2007.
37. W. Hong, R. J. Resnick, C. Rakowski, D. Shalloway, S. J. Taylor, and G. A. Blobel, "Physical and functional interaction between the transcriptional cofactor CBP and the KH domain protein Sam68,"Molecular Cancer Research, vol. 1, no. 1, pp. 48-55, 2002.
38. P. Rajan, L. Gaughan, C. Dalgliesh et al., "TheRNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor," Journal of Pathology, vol. 215, no. 1, pp. 67-77, 2008.
39. L. Song, L. Wang, Y. Li et al., "Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells," Journal of Pathology, vol. 222, no. 3, pp. 227-237, 2010.
40. K. Fu, X. Sun, W. Zheng et al., "Sam68 modulates the promoter specificity of NF-κB and mediates expression of CD25 in activated T cells," Nature Communications, vol. 4, article 1909, 2013.
41. S. Najib, C. Martin-Romero, C. Gonzalez-Yanes, and V. Sanchez-Margalet, "Role of Sam68 as an adaptor protein in signal transduction," Cellular and Molecular Life Sciences, vol. 62, no. 1, pp. 36-43, 2005.
42. J. J. Derry, S. Richard, H. V. Carvajal et al., "Sik (BRK) phosphorylates sam68 in the nucleus and negatively regulates its RNA binding ability,"Molecular and Cellular Biology, vol. 20, no. 16, pp. 6114-6126, 2000.
43. A. H. Andreotti, S. C. Bunnell, S. Feng, L. J. Berg, and S. L. Schreiber, "Regulatory intramolecular association in a tyrosine kinase of the tec family," Nature, vol. 385, no. 6611, pp. 93-97, 1997.
44. C. Sette, M. P. Paronetto, M. Barchi, A. Bevilacqua, R. Geremia, and P. Rossi, "Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase," The EMBO Journal, vol. 21, no. 20, pp. 5386-5395, 2002.
45. M. P. Paronetto, D. Farini, I. Sammarco et al., "Expression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer," The American Journal of Pathology, vol. 164, no. 4, pp. 1243-1251, 2004.
46. R. Busa, M. P. Paronetto, D. Farini et al., "The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells," Oncogene, vol. 26, no. 30, pp. 4372-4382, 2007.
47. K. E. Lukong, D. Larocque, A. L. Tyner, and S. Richard, "Tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression," The Journal of Biological Chemistry, vol. 280, no. 46, pp. 38639-38647, 2005.
48. J. H. Ostrander, A. R. Daniel, and C. A. Lange, "Brk/PTK6 signaling in normal and cancer cell models," Current Opinion in Pharmacology, vol. 10, no. 6, pp. 662-669, 2010.
49. K. T. Barker, L. E. Jackson, and M. R. Crompton, "BRK tyrosine kinase expression in a high proportion of human breast carcinomas," Oncogene, vol. 15, no. 7, pp. 799-805, 1997.
50. J. J. Derry, G. S. Prins, V. Ray, and A. L. Tyner, "Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells," Oncogene, vol. 22, no. 27, pp. 4212-4220, 2003.
51. M.-E. Huot, G. Vogel, and S. Richard, "Identification of a Sam68 ribonucleoprotein complex regulated by epidermal growth factor,"The Journal of Biological Chemistry, vol. 284, no. 46, pp. 31903-31913, 2009.
52. P. Rajan, C. Dalgliesh, C. F. Bourgeois et al., "Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 nuclear bodies," BMC Cell Biology, vol. 10, article 82, 2009.
53. M.-E. Huot, C. M. Brown, N. Lamarche-Vane, and S. Richard, "An adaptor role for cytoplasmic Sam68 inmodulating src activity during cell polarization,"Molecular and Cellular Biology, vol. 29, no. 7, pp. 1933-1943, 2009.
54. R. I. Nicholson, J. M. W. Gee, and M. E. Harper, "EGFR and cancer prognosis,"European Journal of Cancer, vol. 37, no. 4, pp. S9-S15, 2001.
55. W. T. Liao, J. L. Liu, Z. G. Wang et al., "High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer," BMC Gastroenterology, vol. 13, article 126, 2013.
56. Z. Zhang, Y. Xu, N. Sun, M. Zhang, J. Xie, and Z. Jiang, "High Sam68 expression predicts poor prognosis in non-small cell lung cancer," Clinical and Translational Oncology, vol. 16, no. 10, pp. 886-891, 2014.
57. Z. Zhang, J. Li, H. Zheng et al., "Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 10, pp. 2685-2693, 2009.
58. Z. Li, C.-P. Yu, Y. Zhong et al., "Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer," Annals of Oncology, vol. 23, no. 3, pp. 638-646, 2012.
59. J.-P. Yang, T. R. Reddy, K. T. Truong, M. Suhasini, and F. Wong- Staal, "Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K," Oncogene, vol. 21, no. 47, pp. 7187-7194, 2002.
60. S. J. Taylor, R. J. Resnick, and D. Shalloway, "Sam68 exerts separable effects on cell cycle progression and apoptosis," BMC Cell Biology, vol. 5, article 5, 2004.
61. N. Cheung, L. C. Chan, A. Thompson, M. L. Cleary, and C. W. E. So, "Protein arginine-methyltransferase-dependent oncogenesis," Nature Cell Biology, vol. 9, no. 10, pp. 1208-1215, 2007.
62. D. J. Kuhn and Q. P. Dou, "The role of interleukin-2 receptor alpha in cancer," Frontiers in Bioscience, vol. 10, pp. 1462-1474, 2005.
63. S. Pandit, D. Wang, and X.-D. Fu, "Functional integration of transcriptional and RNA processing machineries," Current Opinion in Cell Biology, vol. 20, no. 3, pp. 260-265, 2008.
64. H. P. Phatnani and A. L. Greenleaf, "Phosphorylation and functions of the RNA polymerase II CTD," Genes and Development, vol. 20, no. 21, pp. 2922-2936, 2006.
65. E. Batsche, M. Yaniv, and C. Muchardt, "The human SWI/SNF subunit Brm is a regulator of alternative splicing," Nature Structural and Molecular Biology, vol. 13, no. 1, pp. 22-29, 2006.
66. P. Bielli, R. Busa, S. M. Di Stasi et al., "The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis," EMBO Reports, vol. 15, no. 4, pp. 419-427, 2014.
67. M. Cappellari, P. Bielli, M. P. Paronetto et al., "The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells," Oncogene, vol. 33, no. 29, pp. 3794-3802, 2014.
68. M. Zoller, "CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?" Nature Reviews Cancer, vol. 11, no. 4, pp. 254-267, 2011.
69. Q. Lin, S. J. Taylor, and D. Shalloway, "Specificity and determinants of Sam68 RNA binding. Implications for the biological function of K homology domains," The Journal of Biological Chemistry, vol. 272, no. 43, pp. 27274-27280, 1997.
70. M. Itoh, I. Haga, Q.-H. Li, and J.-I. Fujisawa, "Identification of cellular mRNA targets for RNA-binding protein Sam68," Nucleic Acids Research, vol. 30, no. 24, pp. 5452-5464, 2002.
71. N. Matter, P. Herrlich, and H. Konig, "Signal-dependent regulation of splicing via phosphorylation of Sam68," Nature, vol. 420, no. 6916, pp. 691-695, 2002.
72. L. L. Wang, S. Richard, and A. S. Shaw, "P62 association with RNA is regulated by tyrosine phosphorylation," Journal of Biological Chemistry, vol. 270, no. 5, pp. 2010-2013, 1995.
73. N. H. Meyer, K. Tripsianes, M. Vincendeau et al., "Structural basis for homodimerization of the Src-associated during mitosis, 68-kDa protein (Sam68) Qua1 domain," The Journal of Biological Chemistry, vol. 285, no. 37, pp. 28893-28901, 2010.
74. M. P. Paronetto, M. Cappellari, R. Busa et al., "Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68," Cancer Research, vol. 70, no. 1, pp. 229-239, 2010.
75. C. Valacca, S. Bonomi, E. Buratti et al., "Sam68 regulates EMTthrough alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene," Journal of Cell Biology, vol. 191, no. 1, pp. 87-99, 2010.
76. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation," Cell, vol. 144, no. 5, pp. 646-674, 2011.
77. D. Naor, S. Nedvetzki, I. Golan, L. Melnik, and Y. Faitelson, "CD44 in cancer," Critical Reviews in Clinical Laboratory Sciences, vol. 39, no. 6, pp. 527-579, 2002.
78. P. Y. Godge and L. S. Poonja, "Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study," Indian Journal of Dental Research, vol. 22, no. 3, pp. 493-494, 2011.
79. J. Zeilstra, S. P. J. Joosten, H. vanAndel et al., "StemcellCD44v isoforms promote intestinal cancer formation inApc(min) mice downstreamofWnt signaling," Oncogene, vol. 33, no. 5, pp. 665-670, 2014.
80. W. Muller, A. Schneiders, K.-H. Heider, S. Meier, G. Hommel, and H. E. Gabbert, "Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer," The Journal of Pathology, vol. 183, no. 2, pp. 222-227, 1997.
81. Y. Chen, Z. Fu, S. Xu, Y. Xu, and P. Xu, "The prognostic value of CD44 expression in gastric cancer: a meta-analysis," Biomedicine and Pharmacotherapy, vol. 68, no. 6, pp. 693-697, 2014.
82. S.-T. Wu, G.-H. Sun, D.-S. Hsieh et al., "Correlation of CD44v5 expression with invasiveness and prognosis in renal cell carcinoma," Journal of theFormosanMedical Association, vol. 102, no. 4, pp. 229-233, 2003.
83. N. Matter, M. Marx, S. Weg-Remers, H. Ponta, P. Herrlich, and H. Konig, "Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways," Journal of Biological Chemistry, vol. 275, no. 45, pp. 35353-35360, 2000.
84. A. G. Matera and Z. Wang, "A day in the life of the spliceosome," Nature ReviewsMolecular Cell Biology, vol. 15, no. 2, pp. 108-121, 2014.
85. A. Tisserant and H. Konig, "Signal-regulated pre-mRNA occupancy by the general splicing factor U2AF," PLoS ONE, vol. 3, no. 1, Article ID e1418, 2008.
86. C. Cheng and P. A. Sharp, "Regulation of CD44 alternative splicingby SRm160 and itspotential role in tumor cell invasion," Molecular and Cellular Biology, vol. 26, no. 1, pp. 362-370, 2006.
87. C. J. David and J. L. Manley, "Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged," Genes and Development, vol. 24, no. 21, pp. 2343-2364, 2010.
88. A. Montecucco and G. Biamonti, "Cellular response to etoposide treatment," Cancer Letters, vol. 252, no. 1, pp. 9-18, 2007.
89. G. Biamonti and J. F. Caceres, "Cellular stress and RNA splicing," Trends in Biochemical Sciences, vol. 34, no. 3, pp. 146-153, 2009.
90. M. J. Munoz, M. S. P. Santangelo, M. P. Paronetto et al., "DNA damage regulates alternative splicing through inhibition of RNApolymerase II elongation," Cell, vol. 137, no. 4, pp. 708-720, 2009.
91. M. Dutertre, G. Sanchez, M.-C. de Cian et al., "Cotranscriptional exon skipping in the genotoxic stress response," Nature Structural and Molecular Biology, vol. 17, no. 11, pp. 1358-1366, 2010.
92. M. P. Paronetto, B. Minana, and J. Valcarcel, "The Ewing sarcoma protein regulates DNA damage-induced alternative splicing," Molecular Cell, vol. 43, no. 3, pp. 353-368, 2011.
93. R. Busa and C. Sette, "An emerging role for nuclear RNAmediated responses to genotoxic stress," RNA Biology, vol. 7, no. 4, pp. 390-396, 2010.
94. S. Solier, A. Lansiaux, E. Logette et al., "Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells,"Molecular Cancer Research, vol. 2, no. 1, pp. 53-61, 2004.
95. D. S. Chandler, R. K. Singh, L. C. Caldwell, J. L. Bitler, and G. Lozano, "Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulatorsMDM2 and MDM4," Cancer Research, vol. 66, no. 19, pp. 9502-9508, 2006.
96. Y. Wang, J. L. Dean, E. K. A. Millar et al., "Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists," Cancer Research, vol. 68, no. 14, pp. 5628-5638, 2008.
97. K. E. Knudsen, J. A. Diehl, C. A. Haiman, and E. S. Knudsen, "Cyclin D1: polymorphism, aberrant splicing and cancer risk," Oncogene, vol. 25, no. 11, pp. 1620-1628, 2006.
98. E. A. Musgrove, C. E. Caldon, J. Barraclough, A. Stone, and R. L. Sutherland, "Cyclin D as a therapeutic target in cancer," Nature Reviews Cancer, vol. 11, no. 8, pp. 558-572, 2011.
99. K. Miura, W. Fujibuchi, and M. Unno, "Splice isoforms as therapeutic targets for colorectal cancer," Carcinogenesis, vol. 33, no. 12, pp. 2311-2319, 2012.
100. D. C. Betticher, N. Thatcher, H. J. Altermatt, P. Hoban, W. D. J. Ryder, and J. Heighway, "Alternate splicing produces a novel cyclinD1 transcript," Oncogene, vol. 11, no. 5, pp. 1005-1011, 1995.
101. Z. Li, X. Jiao, C. Wang et al., "Alternative cyclin D1 splice forms differentially regulate theDNAdamage response," Cancer Research, vol. 70, no. 21, pp. 8802-8811, 2010.
102. G. Biamonti, S. Bonomi, S. Gallo, and C. Ghigna, "Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT)," Cellular and Molecular Life Sciences, vol. 69, no. 15, pp. 2515-2526, 2012.
103. J. P. Thiery, H. Acloque, R. Y. J. Huang, and M. A. Nieto, "Epithelial-mesenchymal transitions in development and disease," Cell, vol. 139, no. 5, pp. 871-890, 2009.
104. K. Polyak and R. A. Weinberg, "Transitions between epithelial andmesenchymal states: acquisition of malignant and stem cell traits," Nature Reviews Cancer, vol. 9, no. 4, pp. 265-273, 2009.
105. L. E. Maquat, W. Y. Tarn, and O. Isken, "The pioneer round of translation: features and functions," Cell, vol. 142, no. 3, pp. 368-374, 2010.
106. R. Karni, E. De Stanchina, S. W. Lowe, R. Sinha, D. Mu, and A. R. Krainer, "The gene encoding the splicing factor SF2/ASF is a proto-oncogene," Nature Structural and Molecular Biology, vol. 14, no. 3, pp. 185-193, 2007.
107. C. Ghigna, S. Giordano, H. Shen et al., "Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene,"MolecularCell, vol. 20, no. 6, pp. 881-890, 2005.
108. L. H. Boise, M. Gonzalez-Garcia, C. E. Postema et al., "bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death," Cell, vol. 74, no. 4, pp. 597-608, 1993.
109. D. R. Mercatante, C. D. Bortner, J. A. Cidlowski, and R. Kole, "Modification of alternative splicing of Bcl-x Pre-mRNA in prostate and breast cancer cells. Analysis of apoptosis and cell death," Journal of Biological Chemistry, vol. 276, no. 19, pp. 16411-16417, 2001.
110. D. R. Mercatante, J. L. Mohler, and R. Kole, "Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents," Journal of Biological Chemistry, vol. 277, no. 51, pp. 49374-49382, 2002.
111. J. A. Bauman, S.-D. Li, A. Yang, L. Huang, and R. Kole, "Antitumor activity of splice-switching oligonucleotides," Nucleic Acids Research, vol. 38, no. 22, pp. 8348-8356, 2010.
112. S. Bonomi, S. Gallo, M. Catillo, D. Pignataro, G. Biamonti, and C. Ghigna, "Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy," International Journal of Cell Biology, vol. 2013, Article ID 962038, 17 pages, 2013.
113. D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot, "Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x," Journal of Biological Chemistry, vol. 280, no. 24, pp. 22641-22650, 2005.
114. A. Massiello, J. R. Roesser, and C. E. Chalfant, "SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA," The FASEB Journal, vol. 20, no. 10, pp. 1680-1682, 2006.
115. P. Cloutier, J. Toutant, L. Shkreta, S. Goekjian, T. Revil, and B. Chabot, "Antagonistic effects of the SRp30c protein and cryptic 5′ splice sites on the alternative splicing of the apoptotic regulator Bcl-x,"The Journal of Biological Chemistry, vol. 283, no. 31, pp. 21315-21324, 2008.
116. A. Zhou, A. C. Ou, A. Cho, E. J. Benz Jr., and S.-C. Huang, "Novel splicing factor RBM25 modulates Bcl-x Pre-mRNA 5′ splice site selection,"Molecular and Cellular Biology, vol. 28, no. 19, pp. 5924-5936, 2008.
117. T. Revil, J. Pelletier, J. Toutant, A. Cloutier, and B. Chabot, "Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform," Journal of Biological Chemistry, vol. 284, no. 32, pp. 21458-21467, 2009.
118. M. J. Moore, Q. Wang, C. J. Kennedy, and P. A. Silver, "An alternative splicing network links cell-cycle control to apoptosis," Cell, vol. 142, no. 4, pp. 625-636, 2010.
119. P. Bielli, M. Bordi, V. di Biasio, and C. Sette, "RegulationofBCLX splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection," Nucleic Acids Research, vol. 42, no. 19, pp. 12070-12081, 2014.
120. C. Brignatz, M. P. Paronetto, S. Opi et al., "Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn," Molecular and Cellular Biology, vol. 29, no. 24, pp. 6438-6448, 2009.
121. R. B. Irby and T. J. Yeatman, "Role of Src expression and activation in human cancer," Oncogene, vol. 19, no. 49, pp. 5636-5642, 2000.
122. Z.-Y. Cheny, L. Cai, J. Zhu et al., "Fyn requires hnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer," Carcinogenesis, vol. 32, no. 10, pp. 1419-1426, 2011.
123. S. Rosenberger, J. De.-Castro Arce, L. Langbein, R. D. M. Steenbergenc, and F. Rosla, "Alternative splicing of human papillomavirus type-16 E6/E6∗ early mRNA is coupled to EGF signaling via Erk1/2 activation," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 15, pp. 7006-7011, 2010.
124. H. zur Hausen, "Papillomaviruses and cancer: from basic studies to clinical application," Nature Reviews Cancer, vol. 2, no. 5, pp. 342-350, 2002.
125. S. Sengupta, T. R. Peterson, and D. M. Sabatini, "Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress," Molecular Cell, vol. 40, no. 2, pp. 310-322, 2010.
126. S. Wullschleger, R. Loewith, and M. N. Hall, "TOR signaling in growth and metabolism," Cell, vol. 124, no. 3, pp. 471-484, 2006.
127. J. Paez and W. R. Sellers, "PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling," Cancer Treatment and Research, vol. 115, pp. 145-167, 2003.
128. K. V. Prasanth and D. L. Spector, "Eukaryotic regulatory RNAs: an answer to the genome complexity conundrum," Genes and Development, vol. 21, no. 1, pp. 11-42, 2007.
129. I. Ulitsky and D. P. Bartel, "LincRNAs: genomics, evolution, and mechanisms," Cell, vol. 154, no. 1, pp. 26-46, 2013.
130. T. R. Cech and J. A. Steitz, "The noncoding RNA revolution- trashing old rules to forge new ones," Cell, vol. 157, no. 1, pp. 77-94, 2014.
131. V. Messina, O. Meikar, M. P. Paronetto et al., "The RNA binding protein SAM68 transiently localizes in the chromatoid body of male germcells and influences expression of select microRNAs," PLoS ONE, vol. 7, no. 6, Article ID e39729, 2012.
132. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, "Many roads to maturity: microRNA biogenesis pathways and their regulation," Nature Cell Biology, vol. 11, no. 3, pp. 228-234, 2009.
133. Y. Lee, C. Ahn, J. Han et al., "The nuclear RNase III Drosha initiates microRNA processing," Nature, vol. 425, no. 6956, pp. 415-419, 2003.
134. E. Bernstein, A. A. Caudy, S. M. Hammond, and G. J. Hannon, "Role for a bidentate ribonuclease in the initiation step of RNA interference," Nature, vol. 409, no. 6818, pp. 363-366, 2001.
135. Y. Wang, G. Lacroix, J. Haines, E. Doukhanine, G. Almazan, and S. Richard, "The QKI-6 RNA binding protein localizes with the MBP mRNAs in stress granules of glial cells," PLoS ONE, vol. 5, no. 9, Article ID e12824, 2010.
136. C. DeOcesano-Pereira, M. S. Amaral, K. S. Parreira et al., "Long non-coding RNAINXS is a criticalmediator of BCL-XS induced apoptosis,"Nucleic Acids Research, vol. 42, no. 13, pp. 8343-8355, 2014.